MOREPENLAB.NS
MOREPENLAB.NS
INE083A01026
MOREPEN LAB. LTD
Loading chart...

Company Profile

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, NASH/ MASH treatment products, CKD treatment, and anti-depressant drugs; and home diagnostic and point-of-care medical devices products, such as blood glucose monitor and test strips, blood pressure monitors, respiratory devices, ortho support, digital thermometers, digital weighing scale, fertility, nebulizers, pulse oximeters, vaporizers, orthopaedic, stethoscope, and miscellaneous products. It also provides OTC healthcare products; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. In addition, the company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Related stocks

BLISSGVS.BO
BLISSGVS.BO • India
BLISS GVS PHARMA LTD.
644.55 INR
708.16M USD 1Y +341.4%
SPARC.NS
SPARC.NS • India
SUN PHARMA ADV.RES.CO.LTD
185.6 INR
622.35M USD 1Y +46.6%
IOLCP.BO
IOLCP.BO • India
IOL CHEMICALS & PHARMACEUTICAL
200.85 INR
609.17M USD 1Y +100.2%
AKUMS.NS
AKUMS.NS • India
AKUMS DRUGS AND PHARMA L
751.85 INR
1.19B USD 1Y +78.6%
AARTIPHARM.NS
AARTIPHARM.NS • India
AARTI PHARMALABS LIMITED
855.5 INR
801.58M USD 1Y +2.5%
STAR.NS
STAR.NS • India
STRIDES PHARMA SCI LTD
1,085.3 INR
1.03B USD 1Y +37.4%
2186.HK
2186.HK • China
LUYE PHARMA
1.73 HKD
880.63M USD 1Y -49.7%
PGHL.BO
PGHL.BO • India
PROCTER & GAMBLE HEALTH LIMITE
5,215.55 INR
894.55M USD 1Y -17.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
51.4% p.a.
Max Drawdown (5Y)
-65.0%
Sharpe Ratio (5Y)
0.31
Beta Factor
0.91
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 50.6 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (51.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -82.1% in the extended horizon.
ende